N4 Pharma (LON:N4P) Shares Up 42.9% – Still a Buy?

N4 Pharma Plc (LON:N4P)’s share price rose 42.9% during mid-day trading on Wednesday . The stock traded as high as GBX 0.75 ($0.01) and last traded at GBX 0.75 ($0.01). Approximately 7,667,071 shares traded hands during trading, an increase of 309% from the average daily volume of 1,873,907 shares. The stock had previously closed at GBX 0.53 ($0.01).

N4 Pharma Trading Up 8.3 %

The company has a market capitalization of £2.57 million, a P/E ratio of -55.00 and a beta of -0.37. The business has a 50 day moving average price of GBX 0.62 and a 200 day moving average price of GBX 0.57. The company has a current ratio of 22.73, a quick ratio of 7.28 and a debt-to-equity ratio of 1.62.

About N4 Pharma

N4 Pharma is a specialist pharmaceutical company developing novel delivery systems for oncology, gene therapy and vaccines It has a unique silica nanoparticle delivery system called Nuvec® and another unique peptide.lipid system called Liptide® which it operates through its subsidiary Nanogenics Ltd

N4 Pharma’s business model is to partner with companies developing novel antigens in these fields to use Nuvec® as the delivery vehicle for these antigens.